Zepbound Guide
Zepbound is the brand-name formulation of tirzepatide 2.5–15mg specifically FDA-approved for chronic weight management, launched by Eli Lilly in late 2023. It is chemically identical to Mounjaro but approved specifically for obesity treatment, making it eligible for different insurance coverage pathways and savings programs.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
At a Glance
| Generic Name | Tirzepatide |
| Brand Names | Zepbound |
| FDA Status | FDA-approved for chronic weight management in adults with obesity, or overweight with at least one weight-related comorbidity (November 2023), and to treat moderate-to-severe obstructive sleep apnea in adults with obesity[1] |
| Approval Date | November 8, 2023[1] |
How Zepbound Works
Zepbound works through tirzepatide's dual GIP/GLP-1 mechanism to reduce appetite through both central brain signals and peripheral metabolic effects. GLP-1 activation creates feelings of fullness and slows digestion; GIP activation may additionally enhance fat metabolism and energy expenditure. This twin-hormone approach produces more weight loss than any single-pathway agent.[2]
Dosing Schedule
Zepbound uses a gradual dose escalation to minimize side effects. Always follow your prescriber's guidance and the current FDA label[1].
Side Effects
Common: nausea (25–29%), diarrhea (19–23%), vomiting (8–13%), constipation (11–17%), abdominal pain (9–10%) across the 5, 10, and 15 mg doses, injection site redness. Nausea is most common during dose escalation and typically resolves within a month of each new dose. Serious (rare): pancreatitis, cholelithiasis (gallstones), thyroid tumor risk noted in animal models.[1][2]
This is not a complete list. Consult your healthcare provider or prescriber for full safety information. The complete adverse reaction profile is published in the current FDA prescribing information[1].
Clinical Trial Results
In the SURMOUNT-1 trial, Zepbound (tirzepatide 15mg) produced an average weight loss of 22.5% (about 52 lbs) over 72 weeks — the highest of any anti-obesity medication ever studied. At 10mg, participants lost 21.4%; at 5mg, they lost 15.0%. 91% of participants lost at least 5% of body weight at the 15mg dose.[2][3]
Where to Get Zepbound
These telehealth providers offer access to tirzepatide with online consultations and home delivery. Before you book a consult, our guide to getting Zepbound online walks through eligibility, the prescriber visit, and what legitimate pharmacy fulfillment looks like.
Found
Best for: medication-included compounded GLP-1 from $169/mo on a 12-month prepaid plan, plus brand insurance help
Editorial score · methodology
RxSpan MD
Best for: physician-led, pharmacy-transparent compounded GLP-1 with brand-name options
Editorial score · methodology
Editorial score · methodology
ShedRx
Best for: compounded GLP-1 as an injection, drops or lozenges, with lower rates on 6- and 12-month plans
Editorial score · methodology
GobyMeds
Best for: no-membership, no-auto-renew compounded GLP-1 orders, from about $99/mo on a 3-month bundle
Editorial score · methodology
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Cost Comparison
Each provider's lowest ongoing monthly cash price for Zepbound, sorted cheapest first (no copays, membership fees or intro offers). Both compounded and brand-name prescriptions are generally FSA/HSA eligible under IRS Publication 502[6]. Prices may vary based on dose.
| Provider | From (ongoing) | |
|---|---|---|
| Amazon One Medical | $299/moper 4 weeks | Visit |
| Found | $299/mostarting dose | Visit |
| GoodRx | $299/morises with dose | Visit |
| Heally | $299/mostarting dose | Visit |
| Healthspan | $299/mo+ required membership | Visit |
| Hers | $299/mo+ required membership | Visit |
| Hims | $299/mo+ required membership | Visit |
| HuHealth | $299/mosee plan details | Visit |
| Imbue Health | $299/mo+ required membership | Visit |
| Knownwell | $299/mosee plan details | Visit |
| LifeMD | $299/mo+ required membership | Visit |
| Measured | $299/mo+ required membership | Visit |
| Médetone | $299/mo+ required membership | Visit |
| Ro | $299/mo+ required membership | Visit |
| Sesame Care | $299/mosee plan details | Visit |
| ShedRx | $299/mo+ required membership | Visit |
| Temi | $299/morises with dose | Visit |
| Aspire Health | $348/moper 4 weeks | Visit |
| PreventiveMD | $348/mo“starting at” price | Visit |
| Mochi Health | $378/mo+ added fee | Visit |
| GOAL.MD | $394/mosee plan details | Visit |
| Alloy | $398/mostarting dose | Visit |
| Tuyo Health | $399/mo+ required membership | Visit |
| Phoenix NP | $403/moper 4 weeks | Visit |
| Navio MD | $445/morises with dose | Visit |
| Maximus | $450/mostarting dose | Visit |
| AgelessRx | $514/moafter intro offer | Visit |
| WePeptideRx | $699/moper 4 weeks | Visit |
| Pallas Health | $1,069/moper 4 weeks | Visit |
| RxSpan MD | $1,069/mo | Visit |
| altRX | $1,249/mo | Visit |
| DudeMeds | $1,350/mo3-month plan rate | Visit |
| HeliMeds | $1,396/moper 4 weeks | Visit |
| Aquivia Health | $1,399/mosee plan details | Visit |
| GobyMeds | $1,399/mo | Visit |
| Luvo Health | $1,399/moper 4 weeks | Visit |
| Meant | $1,399/moentry-tier price | Visit |
| Medsol RX | $1,399/mosee plan details | Visit |
| Tomorrow | $1,399/mo | Visit |
| Tryozi | $1,399/mo | Visit |
| Vytora Health | $1,399/mo | Visit |
| Effecty | $1,400/mosee plan details | Visit |
| SkinnyRx | $1,400/mosee plan details | Visit |
| Bon Health | $1,469/mo+ added fee | Visit |
| OrderlyMeds | $1,498/mosee plan details | Visit |
| BiltRx | $1,499/mo+ consult fee | Visit |
| Corsica Health | $1,499/mosee plan details | Visit |
| Livbetr | $1,599/mo | Visit |
| Good Girl Rx | $1,688/mo | Visit |
| Fridays | $1,828/mo | Visit |
| NuuVim | $1,892/mostarting dose | Visit |
Zepbound Head-to-Head Comparisons
Short-form verdict pages comparing Zepbound to other GLP-1 options with trial-anchored data, FDA-label dosing, and current manufacturer pricing.
See all drug-vs-drug verdicts, or compare every weight loss medication we cover.
Pivotal Zepbound Trial Walkthroughs
Endpoint-by-endpoint breakdowns of the trials that shaped the Zepbound label, with primary-source numbers and FAQs.
Zepbound Patient Questions, Answered
Real patient questions about Zepbound pulled from named subreddits and answered with peer-reviewed trial data.
Zepbound Reference Cards
Scannable cheat sheets for dose schedules, missed-dose rules, and red-flag side effects — every number verified against the DailyMed FDA label.
Ranked PubMed Studies on Zepbound
Curated lists of the highest-impact peer-reviewed studies on Zepbound and related GLP-1 drugs. Every PMID is checked against its PubMed record.
Related Research on Zepbound
Deep-dive articles from our research desk with primary-source trial data, FDA label verification, and editorial analysis.
Frequently Asked Questions
Sources & methodology (as of November 2026)
- 1.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 2.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 3.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 4.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 5.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 6.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Tirzepatide · Drugs and brands
- Mounjaro · Drugs and brands
- GLP-1 receptor · Mechanism
- GIP receptor · Mechanism
- Dual agonist · Mechanism
- SURMOUNT-1 · Major trials
- SURMOUNT-OSA · Major trials